INTRODUCTION
============

Diet and exercise interventions in cancer patients may be of benefit for ameliorating adverse events during cancer treatment and may increase overall survival.[@b1-jcp-22-127]--[@b3-jcp-22-127] Metabolic processes in cancer are complex and highly regulated, and there is increasing evidence that dietary modulation can be efficacious in managing cancer, i.e., diet rich in fat and protein[@b4-jcp-22-127] or calorie restriction.[@b5-jcp-22-127],[@b6-jcp-22-127] Calorie restriction has been shown to reduce the pro-growth signaling, partially achieved by temporarily reducing glucose and circulating insulin-like growth factor 1, which is highly associated with aging and cancer.[@b7-jcp-22-127] Also, manipulation of the molecular pathways using calorie restriction has been shown to render cancer cells susceptible to standard cytotoxic treatment with radiation and chemotherapy especially strong for breast cancer. However, considering the high drop-out rate (25%), this indicates that adherence to this low-calorie diet requires high commitment to the study participants.

Ketogenic diet is designed specifically to result in ketosis and is emerging as a metabolic therapy for treating cancer. The mechanism can be explained by inducing shortage of glucose and/or lactate for tumor cells to survive. Vander Heiden et al.[@b8-jcp-22-127] observed that tumors take up enormous amounts of glucose compared to the surrounding tissue and eventually produces lactate through aerobic glycolytic pathway. Therefore, limitation of glucose availability in cancer cell may reduce energy production of cancer cells, and thereby decreasing tumor proliferation.[@b9-jcp-22-127]

The aim of this review is to assess the clinical evidence of ketogenic diet intervention in cancer patients by analyzing human trials.

STUDY SEARCH AND SELECTION
==========================

1. Literature search
--------------------

The eligible literatures were retrieved by searching through databases (PubMed, MEDLINE, and Springer link) from 1985 until July, 2017. Searching keywords included "ketogenic diet" or "ketone", "cancer" or "tumor", and "oncology" with no language restriction and was limited to human clinical trials.

2. Inclusion and exclusion criteria
-----------------------------------

Articles were included under the following criteria: (1) randomized clinical trials with/without control, (2) prospective cohort study, (3) adult population, and (4) ketone diet composition mentioned. The exclusion criteria were as follows: (1) articles with incomplete data, (2) case studies, and (3) reviews. Letters or comments were irrespective.

3. Data extraction
------------------

After the completion of article screening, two investigators independently extracted the data from the eligible studies according to the predesigned protocol. The extracted information was summarized by the first author's name, journal name, publication year, geographical area of study population, mean age of the participants, sample size of the intervention and control groups, detailed dietary regimen and the length of the study, adherence rate, outcome measures, and results of each article, and finally reported side effects.

ELIGIBLE STUDIES
================

The process of search strategy is presented in [Figure 1](#f1-jcp-22-127){ref-type="fig"}. The original search yielded a total of 468 citations (limited to clinical trials, human studies, and years from 1985--2017). First, there were 63 articles after removing the duplicates. Then, 47 articles were excluded because of obvious irrelevance after screening the title and abstract. Six among the remained 16 articles were removed after full-text review: 2 for case studies; 4 without available data. Finally, 10 articles were included in this review. The recommendation of the Cochrane Effective Practice and Organization of Care Review systematic review and meta-analyses, randomized controlled studies, and non-randomized controlled studies were included.[@b10-jcp-22-127]

SUMMARY OF THE STUDY OUTCOMES OF ELIGIBLE ARTICLES
==================================================

The detailed information of ketone diets from the selected articles are summarized in [Table 1](#t1-jcp-22-127){ref-type="table"}.[@b11-jcp-22-127]--[@b20-jcp-22-127]

A total of 214 subjects were included in the review. Most of the studies were intervention trials except for one prospective cohort study. The mean age of the studies was mostly from late fifties to early seventies. Eight out of ten articles were submitted from European countries (Germany and Italy) and only two were from USA. The duration of experimental intervention ranged from 5 days to 2 years and the outcome measures were mainly focused on the body weight and composition and blood profile. One article measured quality of life (QOL). The adherence rate in 5 studies were 100%, and the rest were from 31% to 85%. Reported side effects in the studies were relatively minor and included only few reported constipation, leg cramps, diarrhea, etc. Subjects maintained on ketogenic diet for a relatively short period (2 weeks in the study by Rossi-Fanelli et al.,[@b12-jcp-22-127]; 1 week in the study by Fearon et al.,[@b11-jcp-22-127]; 5 days in the study by Schroeder et al.[@b16-jcp-22-127]) did not show any significant changes of the markers, such as body weight or blood profile except for decrease in lactate concentration in the tumor tissues. Meanwhile, when subjects were maintained for a longer period, such as 8 weeks, ketogenic diet (normal meal + fat-enriched liquid diet) successfully showed increased energy intake and body weight of the subjects.[@b13-jcp-22-127] Ketogenic diet in this study was used for only malnourished gastro-intestinal cancer patient with metastases, suggesting the possibility of application in specific cancer patients. Evaluation on anticancer biomarkers was not measured in most of the articles except for study by Jansen and Walach[@b18-jcp-22-127] who found that TKTL1, a novel marker associated with tumor progression, was reduced by a 2-year ketogenic diet.

Notably, the results from Fine et al.,[@b15-jcp-22-127] Rieger et al.,[@b17-jcp-22-127] and Klement and Sweeney[@b19-jcp-22-127] showed that ketone diet increased significant weight loss. These results showed that unlike the consistent ketogenic effects on epilepsy patients, ketogenic effects on cancer patients were not consistent in this review.

KETOGENIC DIET AS A CANCER THERAPEUTIC STRATEGY
===============================================

Recently, ketogenic diet has been newly emerged as a cancer therapy in both animal models and humans. Some of the preclinical studies have shown the effect of ketogenic diet to reduce tumor growth and improve survival in animal models of malignant glioma,[@b21-jcp-22-127]--[@b23-jcp-22-127] prostate cancer,[@b24-jcp-22-127]--[@b26-jcp-22-127] colon cancer,[@b27-jcp-22-127] and gastrointestinal cancer.[@b28-jcp-22-127] Low calorie diet, such as fasting inducing a state of ketosis, has been shown to enhance the responsiveness of cancer cells to chemotherapy in pre-clinical cancer therapy models and to ameliorate some of chemotherapy-induced side effects in normal tissues.[@b29-jcp-22-127]

More recently, numerous case reports were reported. First report was derived from confirmed glioblastoma multiforme treated with standard therapy together with a restricted ketogenic diet, and the response observed in the case suggested the possibility of calorie-restricted ketogenic diet.[@b30-jcp-22-127]

Ketogenic diet has been studied intensively in the European country including Germany. In these studies, the physical condition was successfully improved and tumor shrinkage was observed by ketogenic diet.[@b14-jcp-22-127] The studies here reviewed lack greatly in the homogeneity of type of cancer, location of cancer, the stages of cancer, and the treatment course of the cancer, and thus the results cannot be generalized. Because ketogenic diet normally results in an increased weight loss, there are continuous concerns to apply this diet for cancer patients. In this review, however, we found that ketogenic diet showed no significant adverse effects. It may be possibly because the subjects were adults, while in children long-term ketogenic diet induces renal damage such as kidney stones.[@b31-jcp-22-127] Any adverse effects reported in this review were constipation, diarrhea, fatigue, etc. In healthy obese adults with low-carbohydrate ketogenic diet for 6 months, the only adverse effects reported were an increase in the level of low-density lipoprotein cholesterol and some shakiness and uneasiness.[@b32-jcp-22-127]

Studies described in this review assessed the effects of a ketogenic diet in cancer patients. Only ten studies were analyzed and the characteristics and study design, the ketogenic diet regimen, the length of study, cancer type and stage, and site were heterogeneous, thereby contributing to a poor conclusion.

As for ongoing clinical trials, there are currently 62 trials assessing low carbohydrate diets as a potential therapy for a variety of diseases of which 13 trials are assessing ketogenic diet as an adjuvant cancer therapy. Three of the studies are not initiated, but, one study with pancreatic cancer patients was terminated because of the low participation and adherence ([Table 2](#t2-jcp-22-127){ref-type="table"}).

CONCLUSION
==========

Our main aim in this review was to assess the feasibility and acceptability of ketogenic diet and to assess the changes of outcome variables, such as body composition, biochemical blood profiles, and QOL. From this review, we found further evidence that ketogenic diet in cancer patients is safe and feasible as an adjuvant therapy. As described above, we could conclude that in order to see any significant progression or improvement by ketogenic diet, at least 3 to 4 weeks of ketogenic diet is required. Additionally, we suggest that not only body composition but also biomarker or measures for tumor size or tumor metabolism assessment is essential. We also conclude that the acceptability for ketone diet may be better in some cancer type (better in glioblastoma than gastric cancer).

In conclusion, ketogenic diet can be safely used to cancer patients if carefully monitored. Most importantly, we have to establish standardized treatment protocol which include the length and regimen for ketogenic diet.
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###### 

Clinical trials (including prospective cohort study) using KD in cancer patients

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author (journal and year)                                         No. of subjects and characteristics                         Cancer type                  KD intervention (duration and regimen)                                                                                                Adherence                                         Outcome measures and results                                                                                                                                 Side effect
  ----------------------------------------------------------------- ----------------------------------------------------------- ---------------------------- ------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------
  Fearon et al.[@b11-jcp-22-127] (Am J Clin Nutr 1988)              Total n = 5\                                                2 Gastric cancer\            6 days balanced enteral formula (BD) → 7 days KD enteral formula (KD)\                                                                100%                                              BD\                                                                                                                                                          No GI upset
                                                                    Cachectic patients (mean age, 61 yr)\                       2 Lung cancer\               BD: kcal: 44 kcal/kg/d\                                                                                                                                                                  No change of body weight\                                                                                                                                   
                                                                    Country: Italy                                              1 Ovarian cancer              prot: 1.5 g/kg/d\                                                                                                                                                                       No change of nitrogen balance\                                                                                                                              
                                                                                                                                                              (55% carbohydrate, 31% fat)\                                                                                                                                                            No change of prot turnover\                                                                                                                                 
                                                                                                                                                             KD: kcal: 44 kcal/kg/d\                                                                                                                                                                 KD\                                                                                                                                                          
                                                                                                                                                              prot: 1.5 g/kg/d (whey)\                                                                                                                                                                Increased body weight\                                                                                                                                      
                                                                                                                                                              4.4 mmol argninine/kg/d\                                                                                                                                                                No change of nitrogen balance\                                                                                                                              
                                                                                                                                                               (70% of calorie as MCT)                                                                                                                                                                No change of prot turnover                                                                                                                                  

  Rossi-Fanelli et al.[@b12-jcp-22-127] (Clin Nutr 1991)            Total n = 27\                                               9 Oesophagus\                14 days intervention\                                                                                                                 100%                                              No group differences were found in S-phase fraction of cell cycle\                                                                                           Not mentioned
                                                                    TNM staged\                                                 9 Stomach\                   Iso-kaloric regimen\                                                                                                                                                                     Total lymphocyte counts\                                                                                                                                    
                                                                    Arm A: n = 9 (median age, 61 yr)\                           9 Colorectal                 Arm A: parenteral nutrition\                                                                                                                                                             Blood glucose\                                                                                                                                              
                                                                    Arm B: n = 9 (median age, 70 yr)\                                                         100% dextrose\                                                                                                                                                                          Triglycerides\                                                                                                                                              
                                                                    Arm C: n = 9 (median age, 67 yr)\                                                         0.24 g/kg/d amino-acid\                                                                                                                                                                 Body weight\                                                                                                                                                
                                                                    Country: Italy                                                                            Vitamin minerals\                                                                                                                                                                       Mid-arm circumferences\                                                                                                                                     
                                                                                                                                                             Arm B: parenteral nutrition 80% as fat, 20%\                                                                                                                                             Serum albumin\                                                                                                                                              
                                                                                                                                                              as dextrose\                                                                                                                                                                            Pre-albumin\                                                                                                                                                
                                                                                                                                                              0.24 g/kg/d amino-acid\                                                                                                                                                                 Transferrin\                                                                                                                                                
                                                                                                                                                              Vitamin minerals\                                                                                                                                                                       Retinol-binding prot                                                                                                                                        
                                                                                                                                                             Arm C: oral diet                                                                                                                                                                                                                                                                                                                                     

  Breitkreutz et al.[@b13-jcp-22-127] (Wien Klin Wochenschr 2005)   Total n = 23\                                               12 Colorectal\               Group A\                                                                                                                              100%                                              Group A\                                                                                                                                                     Not mentioned
                                                                    Moderately malnourished cancer patients\                    11 Gastric\                   8 weeks of 35 kcal/kg/d, 1.1 g prot/kg/d\                                                                                                                                               Average intake 1,556 ± 497 kcal\                                                                                                                            
                                                                    Group A: n = 11 (mean age, 60.6 yr)\                        All metastases                (normal meals)\                                                                                                                                                                         Progressive weight loss\                                                                                                                                    
                                                                    Group B: n = 12 (mean age, 58.8 yr)\                                                      Nutritional counseling every 14 days\                                                                                                                                                   Progressive loss of FFM\                                                                                                                                    
                                                                    Country: Germany                                                                         Group B\                                                                                                                                                                                 Decrease in serum albumin\                                                                                                                                  
                                                                                                                                                              8 weeks of 20 kcal/kg/d, 1.1 g prot/kg/d\                                                                                                                                               No change TLC\                                                                                                                                              
                                                                                                                                                              (fat-enriched liquid diet + normal meals)\                                                                                                                                              No change of QOL\                                                                                                                                           
                                                                                                                                                              Nutritional counseling every 14 days                                                                                                                                                   Group B\                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                      Average intake 1,865 ± 317 kcal\                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                      Increased body weight\                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                      Progressive increase of FFM\                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                      No change in serum albumin\                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                      Significant decrease of TLC\                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                      No change of QOL                                                                                                                                            

  Schmidt et al.[@b14-jcp-22-127] (Nutr Metab (Lond) 2011)          Total n = 16\                                               3 Ovarian cancer\            3 months of low CHO diet (KD) - CHO limitation to 70 g/d, 20 g/meal- 2 liquid meals (21 g fat, 5 g CHO, 14 g prot)/meal               31% (2 died, 9 dropped out)                       KD\                                                                                                                                                          No diet related adverse events
                                                                    Metastatic tumors (mean age, 50.4 yr)\                      1 Breast cancer\                                                                                                                                                                                                      3 patients reached ketosis\                                                                                                                                 
                                                                    Country: Germany                                            1 Osteosarcoma\                                                                                                                                                                                                       No change: Global health status\                                                                                                                            
                                                                                                                                5 Gastrointestinal cancer\                                                                                                                                                                                             Functional score\                                                                                                                                          
                                                                                                                                2 Thyroid cancer\                                                                                                                                                                                                      Blood glucose, TG\                                                                                                                                         
                                                                                                                                1 Endometrial\                                                                                                                                                                                                         creatinine, Albumin\                                                                                                                                       
                                                                                                                                1 Lung cancer\                                                                                                                                                                                                        Increase: appetite loss, constipation\                                                                                                                      
                                                                                                                                1 Granulosa cell tumor\                                                                                                                                                                                                Diarrhea (at 4 wk)\                                                                                                                                        
                                                                                                                                1 Parotis carcinoma                                                                                                                                                                                                   Increase: fatigue, pain\                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                      Decrease: insomnia                                                                                                                                          

  Fine et al.[@b15-jcp-22-127] (Nutrition 2012)                     Total n = 109\                                              2 Breast cancer\             26--28 days KD intervention - \< 5% of kcal as CHO- Increase fat and prot encouraged                                                  100%                                              KD\                                                                                                                                                          No unsafe adverse effects\
                                                                    Incurable, advanced cancer (mean age, 62.9 yr)\             3 Colorectal\                                                                                                                                                                                                         Increased weight loss (−3.0 kg)\                                                                                                                            Except constipation, leg cramps, reversible fatigue
                                                                    Country: USA                                                1 Ovary\                                                                                                                                                                                                              Energy deficit (−35%)\                                                                                                                                      
                                                                                                                                1 Fallopian tube\                                                                                                                                                                                                     No change of serum glucose\                                                                                                                                 
                                                                                                                                2 Lung\                                                                                                                                                                                                               Increased dietary ketosis\                                                                                                                                  
                                                                                                                                1 Esophagus                                                                                                                                                                                                           Inverse relationship of insulin vs. β-hydroxybutyrate                                                                                                       

  Schroeder et al.[@b16-jcp-22-127] (Nutr Cancer 2013)              Total n = 12\                                               2 Larynx\                    5 days KD intervention\                                                                                                               100%                                              KD\                                                                                                                                                          Not mentioned
                                                                    Head and neck cancer (mean age, 64 yr)\                     3 Oral cavity\               Microdialysis                                                                                                                                                                            Increase of urea in tumor tissues\                                                                                                                          
                                                                    Country: Germany                                            2 Hypopharynx\                                                                                                                                                                                                        No change in plasma glucose\                                                                                                                                
                                                                                                                                3 Oropharynx\                                                                                                                                                                                                         Decrease in lactate concentration in tumor tissues\                                                                                                         
                                                                                                                                Unknown primary                                                                                                                                                                                                       Decrease in lactate/pyruvate ratio                                                                                                                          

  Rieger et al.[@b17-jcp-22-127] (Int J Oncol 2014)                 Total n = 20\                                               Recurrent malignant glioma   36 days intervention\                                                                                                                 85%                                               KD\                                                                                                                                                          Few reports on diarrhea, constipation but no major concern or toxicity
                                                                    Patient from ERGO trial (mean age, 57 yr)\                                               KD diet: ketogenic ratio, 3.41 : 1 - CHO limitation to less than 60 g/d- No calorie restriction- 500 mL yoghurt + plant oil                                                              Increased weight loss\                                                                                                                                      
                                                                    Country: Germany                                                                                                                                                                                                                                                                  No change in blood glucose, HbA1c, lipid profiles\                                                                                                          
                                                                                                                                                                                                                                                                                                                                                      Leukcytopenia in 2 patients\                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                      Overall survival 32 weeks                                                                                                                                   

  Jansen and Walach[@b18-jcp-22-127] (Oncol Lett 2016)              Total n = 78\                                               18 Breast\                   10 mo--2 yr\                                                                                                                          Not mentioned                                     KD\                                                                                                                                                          Not mentioned
                                                                    Prospective cohort study (mean age, 68 yr)\                 16 Prostate\                 65 not ketogenic\                                                                                                                                                                        Reduction of TKTL1 (novel marker associated with tumor progression)\                                                                                        
                                                                    Country: Germany                                            9 Colon\                     6 partially ketogenic\                                                                                                                                                                   3 out of 7 patients had improvement\                                                                                                                        
                                                                                                                                5 Lung\                      7 fully ketogenic                                                                                                                                                                        1 had full remission                                                                                                                                        
                                                                                                                                5 Otoharyngeal\                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                25 Other                                                                                                                                                                                                                                                                                                                                                                          

  Klement and Sweeney[@b19-jcp-22-127] (BMC Res Notes 2016)         Total n = 6 (mean age, 60.3 yr)\                            1 Breast\                    32--73 d\                                                                                                                             Not mentioned                                     KD - Decreased BW in 2 patients- Decreased fat mass in 2 patients- No change in hydration status- Decreased phase angle- Increased ketone body               Not mentioned
                                                                    Country: Germany                                            1 Prostate\                  KD with weekly counseling - CHO limitation to 50 g/d- Encourage to consume olive oil, coconut oil, butter, fatty fish, cheese, meat                                                                                                                                                                                                                  
                                                                                                                                3 Rectum\                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                1 Lung during RT                                                                                                                                                                                                                                                                                                                                                                  

  Tan-Shalaby et al.[@b20-jcp-22-127] (Nutr Metab (Lond) 2016)      Total n = 17\                                               6 Gastrointestinal\          16 weeks (checked every 4 wk)\                                                                                                        64.7% (6 for 8 wk, 4 for 16 wk, 3 beyond 16 wk)   KD - 13% wt loss at week 16No changes in glucose, creatinine, SBP/DBP, lipid profile, WBC count, uric acid, albumin, ALTSlight improvement of EORTC QLQ-30   8 Weight loss\
                                                                    Advanced cancer pts not on hemotherapy (mean age, 65 yr)\   2 Lung\                      KD - CHO limitation to 20--40 g/d (no restriction of cal, prot, fat)                                                                                                                                                                                                                                                                                 7 Hyperuicemia\
                                                                    Country: USA                                                3 Skin cancer\                                                                                                                                                                                                                                                                                                                                                                    2 Hyperlipidemia\
                                                                                                                                1 Prostate\                                                                                                                                                                                                                                                                                                                                                                       2 Pedal edema\
                                                                                                                                1 Thyroid\                                                                                                                                                                                                                                                                                                                                                                        2 Anemia\
                                                                                                                                2 Brain cancer\                                                                                                                                                                                                                                                                                                                                                                   2 Halitosis\
                                                                                                                                1 Head/neck\                                                                                                                                                                                                                                                                                                                                                                      2 Pruritus\
                                                                                                                                1 Renal                                                                                                                                                                                                                                                                                                                                                                           2 Hypoglycemia\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  2 Hyperkalemia\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  2 Hypokalemia\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  2 Hypomagnesemia\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  2 Flu-like symptom
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

KD, ketogenic diet; BD, balanced diet; MCT, medium chain triglyceride; prot, protein; GI, gastrointestinal; FFM, fat free mass; TLC, total lymphocyte count; QOL, quality of life; CHO, carbohydrate; TG, total cholesterol; RT, radiation therapy; BW, body weight; wt, weight; SBP, systolic blood pressure; DBP, diastolic blood pressure; WBC, white blood cell; ALT, alanine aminotransferase; EORTC QLQ-30, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30.

###### 

Ongoing clinical trials from clinicalTrials.gov (<https://clinicaltrials.gov>) (accessed on 08/04/2017)

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
       Title                                                                                                                Recruitment               Study Results          Conditions                         Interventions
  ---- -------------------------------------------------------------------------------------------------------------------- ------------------------- ---------------------- ---------------------------------- ------------------------------------------------------------------------------
  1    Ketogenic Diet for Recurrent Glioblastoma                                                                            Completed                 Has results            Recurrent glioblastoma             Dietary supplement: TAVARLIN

  2    Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: A Pilot Study                Recruiting                No results available   Glioblastoma multiforme            Other: ketogenic diet

  3    Ketogenic Diet and Prostate Cancer Surveillance Pilot                                                                Enrolling by invitation   No results available   Prostate cancer                    Other: surveillance

  4    Ketogenic Diet Adjunctive to Salvage Chemotherapy for Recurrent Glioblastoma: A Pilot Study                          Recruiting                No results available   Glioblastoma multiforme            Dietary supplement: ketogenic diet\
                                                                                                                                                                                                                Dietary supplement: standard diet

  6    Impact of a Ketogenic Diet Intervention During Radiotherapy on Body Composition                                      Recruiting                No results available   Neoplasms                          Dietary supplement: ketogenic breakfast\
                                                                                                                                                                                                                Dietary supplement: ketogenic diet\
                                                                                                                                                                                                                Radiation: radio(chemo)therapy

  7    Ketogenic Diet Phase 1 for Head & Neck Cancer                                                                        Terminated                No results available   Head and neck neoplasms            Dietary supplement: Ketogenic diet

  8    Ketogenic Diet With Concurrent Chemoradiation for Pancreatic Cancer                                                  Terminated                No results available   Pancreatic neoplasms               Dietary supplement: ketogenic diet

  9    Ketogenic Diet Treatment Adjunctive to Radiation and Chemotherapy in Glioblastoma Multiforme: A Pilot Study          Recruiting                No results available   Glioblastoma multiforme of brain   Other: ketogenic diet\
                                                                                                                                                                                                                Other: standardized diet

  10   Calorie-restricted, Ketogenic Diet and Transient Fasting During Radiation for Patients With Recurrent Glioblastoma   Recruiting                No results available   Recurrent glioblastoma             Dietary supplement: calorie-restricted ketogenic diet and transient fasting\
                                                                                                                                                                                                                Dietary supplement: standard nutrition

  11   Ketogenic Diets as an Adjuvant Therapy in Glioblastoma                                                               Recruiting                No results available   Glioblastoma\                      Other: MKD\
                                                                                                                                                                             Glioblastoma multiforme            Other: MCT

  12   Restricted Calorie Ketogenic Diet as a Treatment in Glioblastoma Multiforme                                          Recruiting                No results available   Glioblastoma multiforme            Other: ketogenic diet

  13   Ketogenic Diet in Advanced Cancer                                                                                    Completed                 Has results            Cancer                             Other: ketogenic diet
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

MKD, modified ketogenic diet; MCT, medium chain triglyceride ketogenic diet.
